Santhera Pharmaceuticals
SANN.SW
#8700
Rank
S$0.14 B
Marketcap
$12.00
Share price
-5.05%
Change (1 day)
-19.41%
Change (1 year)

EPS for Santhera Pharmaceuticals (SANN.SW)

EPS in 2018 (TTM): -$50.75

According to Santhera Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$17.00. In 2022 the company made an earnings per share (EPS) of -$17.00 an increase over its 2021 EPS that were of -$23.87.

EPS history for Santhera Pharmaceuticals from 2006 to 2018

Annual EPS

Year EPS Change
2022-$17.00-28.75%
2021-$23.87-69.23%
2020-$77.56222.64%
2019-$24.04-77.65%
2018-$107.56-5.34%
2017-$113.6352.2%
2016-$74.65-593.67%
2015$15.12-165.72%
2014-$23.01-2.15%
2013-$23.52-81.35%
2012-$126.1115.64%
2011-$109.05145.81%
2010-$44.36-53.37%
2009-$95.14-152.24%
2008$182.11-270.36%
2007-$106.90-33.09%
2006-$159.76